Raffi Minasian

Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial

Hiddo J L Heerspink, M Jardine, Donald E. Kohan, Richard Lafayette et autres

nl, au, us, ca, sg, cn, br, kr, ar, ch, gb (code pays fourni par la source)

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, Charles E. Alpers et autres

us, gb, nl, au, kr, de, it, be, pl, br, es, hk, cz, ar (code pays fourni par la source)

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, Jonathan Barratt et autres

nl, au, us, gb, br, ar (code pays fourni par la source)

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, George L. Bakris et autres

nl, dk, us, mx, cn, jp, gb, au, ca (code pays fourni par la source)

Patient with a total artificial heart maintained on outpatient dialysis while listed for combined organ transplant, a single center experience

Ramy M. Hanna, Huma Hasnain, Mohammad Kamgar, Mina Hanna et autres

us (code pays fourni par la source)

Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease

Rajiv Agarwal, Adel R. Rizkala, Marwan Kaskas, Raffi Minasian et autres

us (code pays fourni par la source)

[USE OF PLASMA TRANSFUSION IN COMBINED TREATMENT OF E. COLI INFECTIONS IN CHILDREN].

Raffi Minasian, M P Demchenko, Z P Bogoiavlenskaia